NTHI · Company research
NeOnc Technologies Holdings, Inc. (NTHI): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A 3-year-old with a brain tumor is beginning to move his legs after an experimental nasal treatment. - Stock Titan | A 3-year-old with a brain tumor is beginning to move his legs after an experimental nasal treatment. Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi | NeOnc Technologies announced early clinical improvements in a critically ill three-year-old boy treated with investigational intranasal NEO100 through its Compassionate Care program in Abu Dhabi. The patient is now breathing independently without ventilator support and showing renewed leg movement. The company emphasized these observations involve a single patient and do not establish efficacy or predict outcomes in other patients. | View source ↗ | GlobeNewswire Inc. | Oct 16, 2026 | bullish | 1 | 1 |
| NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi | NeOnc Technologies announced early clinical improvements in a critically ill three-year-old boy treated with investigational intranasal NEO100 through its Compassionate Care program in Abu Dhabi. The patient is now breathing independently without ventilator support and showing renewed leg movement. The company emphasized these observations involve a single patient and do not establish efficacy or predict outcomes in other patients. | View source ↗ | GlobeNewswire Inc. | Oct 16, 2026 | bullish | 1 | 1 |
| A 3-year-old with an aggressive brain tumor is breathing without a ventilator, doctors report. - Stock Titan | A 3-year-old with an aggressive brain tumor is breathing without a ventilator, doctors report. Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| NeOnc Technologies (NTHI) lists Ali Mohammad Ahmad Mohammad Alabedin as a director. - Stock Titan | NeOnc Technologies (NTHI) lists Ali Mohammad Ahmad Mohammad Alabedin as a director. Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| Two experimental cancer drugs from NeOnc have UAE authorizations. Its CEO will speak in Abu Dhabi. - Stock Titan | Two experimental cancer drugs from NeOnc have UAE authorizations. Its CEO will speak in Abu Dhabi. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Abu Dhabi opened a potential path to test NeOnc's brain cancer drug; ethics approvals are still needed. - Stock Titan | Abu Dhabi opened a potential path to test NeOnc's brain cancer drug; ethics approvals are still needed. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors | NeOnc Technologies announced the appointment of Ali Alabedin, Head of Islamic Banking Group at First Abu Dhabi Bank, to its Board of Directors effective October 9, 2026. The appointment strengthens financial governance as NeOnc advances its clinical programs and expands operations in Abu Dhabi. The Department of Health – Abu Dhabi has granted IND authorization for NEO212, supporting Phase 2 development in the UAE. | View source ↗ | GlobeNewswire Inc. | Oct 14, 2026 | bullish | 1 | 1 |
| NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors | NeOnc Technologies announced the appointment of Ali Alabedin, Head of Islamic Banking Group at First Abu Dhabi Bank, to its Board of Directors effective October 9, 2026. The appointment strengthens financial governance as NeOnc advances its clinical programs and expands operations in Abu Dhabi. The Department of Health – Abu Dhabi has granted IND authorization for NEO212, supporting Phase 2 development in the UAE. | View source ↗ | GlobeNewswire Inc. | Oct 14, 2026 | bullish | 1 | 1 |
| NeOnc Technologies Holdings, Inc. (NTHI) Stock Price, News, Quote & History - Yahoo! Finance Canada | NeOnc Technologies Holdings, Inc. (NTHI) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 10, 2026 | neutral | 0 | 0.6 |
| NeOnc reports one patient’s brain tumor shrank about 60% on its experimental drug - Stock Titan | NeOnc reports one patient’s brain tumor shrank about 60% on its experimental drug Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| One brain cancer patient's tumor shrank about 60% in a trial. NeOnc is scheduled to meet FDA Nov. 17. - Stock Titan | One brain cancer patient's tumor shrank about 60% in a trial. NeOnc is scheduled to meet FDA Nov. 17. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| NeOnc Technologies (NTHI) CFO sells shares under preset plan - Stock Titan | NeOnc Technologies (NTHI) CFO sells shares under preset plan Stock Titan | View source ↗ | Stock Titan | Sep 18, 2026 | neutral | 0 | 0.6 |
| A cancer drug study beat its 20% benchmark. NeOnc executives bought $629,000 in shares. - Stock Titan | A cancer drug study beat its 20% benchmark. NeOnc executives bought $629,000 in shares. Stock Titan | View source ↗ | Stock Titan | Sep 16, 2026 | neutral | 0 | 0.6 |
| $NTHI stock is down 22% today. Here's what we see in our data. - Quiver Quantitative | $NTHI stock is down 22% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 8, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: CEO of $NTHI Buys 12,757 Shares | NTHI Stock News - Quiver Quantitative | Insider Purchase: CEO of $NTHI Buys 12,757 Shares | NTHI Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 21, 2026 | neutral | 0 | 0.6 |
| Founder of NeOnc Technologies Holdings Thomas Chen Buys 1.0% More Shares - Simply Wall Street | Founder of NeOnc Technologies Holdings Thomas Chen Buys 1.0% More Shares Simply Wall Street | View source ↗ | Simply Wall Street | Aug 20, 2026 | neutral | 0 | 0.6 |
| $NTHI stock is down 15% today. Here's what we see in our data. - Quiver Quantitative | $NTHI stock is down 15% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 19, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: CEO of $NTHI Buys 12,000 Shares | NTHI Stock News - Quiver Quantitative | Insider Purchase: CEO of $NTHI Buys 12,000 Shares | NTHI Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 17, 2026 | neutral | 0 | 0.6 |
| NeOnc Technologies shares jump after positive Phase 2a glioma results - Yahoo Finance | NeOnc Technologies shares jump after positive Phase 2a glioma results Yahoo Finance | View source ↗ | Yahoo Finance | Aug 12, 2026 | neutral | 0 | 0.6 |
| NeOnc Technologies (NTHI) Could Be Targeting A Challenging Market With A Different Strategy - Yahoo Finance | NeOnc Technologies (NTHI) Could Be Targeting A Challenging Market With A Different Strategy Yahoo Finance | View source ↗ | Yahoo Finance | May 31, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.